Runx regulation of sphingolipid metabolism and survival signaling.
Runx regulation of sphingolipid metabolism and survival signaling.
复制标题
DOI:
10.1158/0008-5472.can-10-0726
复制
发表时间:
2010-07-15
期刊:
影响因子:
11.2
通讯作者:
Neil JC
中科院分区:
文献类型:
--
作者:
Kilbey A;Terry A;Jenkins A;Borland G;Zhang Q;Wakelam MJ;Cameron ER;Neil JC
The Runx genes (Runx1, 2 and 3) regulate cell fate in development and can operate as either oncogenes or tumour suppressors in cancer. The oncogenic potential of ectopic Runx expression has been demonstrated in transgenic mice that develop lymphoma in potent synergy with over-expressed Myc, and in established fibroblasts that display altered morphology and increased tumorigenicity. Candidate oncogenic functions of over-expressed Runx genes include resistance to apoptosis in response to intrinsic and extrinsic stresses. In a search for gene targets responsible for this aspect of Runx phenotype we have identified three key enzymes in sphingolipid metabolism (Sgpp1, Ugcg and St3gal5/Siat9) as direct targets for Runx transcriptional regulation, in a manner consistent with survival and apoptosis resistance. Consistent with these changes in gene expression, mass spectrometric analysis demonstrated that ectopic Runx reduces intracellular long chain ceramides in NIH3T3 fibroblasts and elevated extracellular sphingosine 1 phosphate (S1P). Runx expression also opposed activation of JNK and p38MAPK, key mediators of ceramide-induced death, and suppressed the onset of apoptosis in response to exogenous TNFα. The survival advantage conferred by ectopic Runx could be partially recapitulated by exogenous S1P and was accompanied by reduced phosphorylation of p38MAPK. These results reveal a novel link between transcription factor oncogenes and lipid signalling pathways involved in cancer cell survival and chemoresistance.